Expression Genetics, Inc.
Expression Genetics, Inc. is named on 0 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 0
- Published applications
- 5
- Inventors
- 13
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
By publication year.
Technology areas
Share of 5 documents
- A61KMedicines and medical preparations5
- A61PTherapeutic uses of medicines2
- C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds2
- C07KPeptides1
- C12NMicroorganisms or enzymes1
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1
Recent patents
No granted patents yet.
- Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof4 May 2006US 2006/0093674 A1
- Novel cationic lipopolymer as a biocompatible gene delivery agent22 Jul 2004US 2004/0142474 A1
- GLP-1 gene delivery for the treatment of type 2 diabetes27 Nov 2003US 2003/0220274 A1
- Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier23 Jan 2003US 2003/0018002 A1
- Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents3 Oct 2002US 2002/0141965 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.